Abcely
PrivateLast Round
Seed
Sep 22, 2023
Total Funding Raised
$2.6M
Company Overview
Abcely is a biotechnology company developing a proprietary platform for orally active sIgA-based immunotherapy to treat mucosal cancers and chronic mucosal diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abcely Comparables
Compare Abcely with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mage Biologics Inc. | 78% | |
| Epsilogen | 77% | |
| Sorriso Therapeutics | 72% | |
Abcely Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 22, 2023 |
Key People
Founding team and executive leadership
Abcely Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MATWIN | Seed |
| GO Capital | Seed |
| Angels Santé | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 22, 2023
$2.6M round from GO Capital and 3Biotech
Abcely Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Abcely's valuation, stock price, and market status.